Patent · US Expired

Imaging agents

US7410943B2 · kind B2 · utility

6Cited by
1References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 21, 2004
Grant dateAug 12, 2008
Priority date
Expiry dateJul 21, 2024

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to compounds of formula (I): and their use as targeting vectors that bind to receptors associated with angiogenesis. Such compounds may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's sarcoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.